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ABSTRACT
An important model system for studying the process
leading to productive transcription is provided by the
superfamily of nuclear receptors, which are for the
most part ligand-controlled transcription factors.
Over the past years several ‘orphan’ nuclear recep-
tors have been isolated for which no ligand has yet
been identified. Very little is known about how these
‘orphan’ receptors regulate transcription. In this
study we have analysed the biochemical and tran-
scriptional properties of the neuronally expressed
orphan nuclear receptor RORβ (NR1F2) and
compared them with the retinoic acid receptor
heterodimer RXRα–RARα (NR2B1–NR1B1) and Gal–
VP16 in vitro. Although RORβ binds to its DNA-
binding sites with comparatively low affinity, it
efficiently directs transcription in nuclear extracts
derived from a neuronal cell line, Neuro2A, but not in
nuclear extracts from non-neuronal HeLa cells. In
contrast, RXRα–RARα and the acidic transcription
factor Gal–VP16 support transcription in Neuro2A
and HeLa nuclear extracts equally efficiently. These
observations point to a different (co)factor require-
ment for transactivation by members of the NR1
subfamily of nuclear receptors.
INTRODUCTION
The spatio-temporal regulation of gene expression is one of the
key issues in differentiation and development. A central role in
the control of gene expression is played by transcription
factors that bind to specific enhancer/promoter elements and
activate or repress transcription of a specific gene. The
complex mechanism of transcriptional activation permits tight
control at multiple levels, such as binding of the transcription
factor to its response element, recruitment of co-activator/co-
repressor complexes and the basal transcription machinery and
facilitating reinitiation of transcription.
Among many model systems the nuclear receptors of the
thyroid/steroid superfamily have been of particular importance
in the continuing dissection of the mechanisms responsible for
control of transcription. The nuclear receptor superfamily now
comprises more than 50 distinct members which have been
grouped into six different subfamilies based on sequence simi-
larities in the two well-conserved regions of this family, the
DNA-binding and the ligand-binding domains (1).
The ‘classical’ nuclear receptor acts as a ligand-controlled
transcription factor which responds either to steroid hormones,
small lipophilic molecules or vitamins. The last few years have
witnessed major breakthroughs in understanding the molecular
mechanisms of transcription signal transmission by these
receptors (for reviews see 2,3 and references therein). In addi-
tion to these ‘classical’ receptors, a rather large number of
proteins have been identified that share the overall protein
structure of nuclear receptor family members but for which no
ligand has (yet) been found. These receptors are commonly
referred to as ‘orphan’ receptors (4).
Some orphan receptors have DNA-binding and dimerisation
properties very similar to those of ‘classical’ receptors,
including their ability to bind as homodimers or RXR
heterodimers to half-sites arranged either as a palindrome or
direct repeats. However, a subgroup of orphan receptors exists
that bind as monomers to so-called extended half-sites. Nucle-
otides 5′ of the conserved receptor half-site (AGGTCA) are
contacted by these orphan receptors increasing DNA binding
affinity and providing specificity in the recognition of mono-
meric response elements (5). An intriguing question is how the
transcriptional activity of orphan receptors is regulated in the
absence of a ligand and of a heterodimerisation partner. It is
possible that the transcriptional activity of orphan receptors is
controlled by protein modifications. Alternatively, these recep-
tors may display a constitutive ability to bind either co-
repressor or co-activator complexes.
A good model system for studying transcriptional control by
orphan receptors that bind to DNA as monomers is the
subgroup of the ROR (NR1F) (also referred to as RZR) and the
Rev-erb (NR1D) receptors. In transient transfections members
of the ROR subgroup appear to act as constitutive activators,
whereas members of the Rev-erb subgroup act as constitutive
repressors.
Two members of the ROR subgroup, RORα (NR1F1) (6,7)
and RORβ (NR1F2) (8), are highly related but display very
different expression patterns. While RORα is ubiquitously
expressed, RORβ expression is restricted to neuronal cells, in
particular to areas in the central nervous system that are
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involved in the processing of sensory information (spinal cord,
thalamus and sensory cerebellar cortices) and the major areas
of circadian rhythm regulation (retina, pineal gland and supra-
chiasmatic nuclei) (9). Despite the high degree of amino acid
similarity, we recently demonstrated that these two receptors
display different DNA-binding behaviors (10), suggesting that
specific transcriptional regulation mechanisms may be in place
for these transcription factors.
To unravel the mechanism underlying regulation of tran-
scription by monomeric binding orphan receptors, we
expressed RORβ using the vaccinia virus system and
compared its DNA-binding and transcriptional properties with
those of the RXRα–RARα (NR2B1–NR1B1) heterodimer and
the synthetic acidic activator Gal–VP16 in vitro. In this report
we show that although RORβ has a weak affinity for its
response elements compared with the RXRα–RARα
heterodimer, it potently drives transcription in Neuro2A but
not in HeLa nuclear extracts. RXRα–RARα and Gal–VP16 are
able to efficiently activate transcription in both Neuro2A and
HeLa nuclear extracts.
MATERIALS AND METHODS
Recombinant vaccinia viruses
Recombinant vaccinia viruses expressing His6–RORβ and
RXRα–His6–RARα were prepared according to the protocol
described (10,11). The expression vector for RORβ contained the
RORβ1 cDNA (8) in pMS56 (12). The amino acids -MSHHHH-
HHGEF precede the second amino acid of the RORβ sequence.
Receptor purification and western blotting
Preparation of nuclear extracts from virus-infected cells
followed by Ni2+–NTA chromatography purification were
performed essentially as described (10,11,13). Western blot-
ting was performed as previously described (10). Signal detec-
tion was performed using the AP kit (Promega).
Oligonucleotides
The synthetic oligonucleotides used in this study comprised
nuclear receptor binding sites (listed in Fig. 2A) and SacI
flanking sequences.
Electromobility shift assays
For the preparation of 32P-labelled oligonucleotides, two
complementary single-stranded oligos were annealed and
incubated with [γ-32P]dATP and T4 polynucleotide kinase
(BioLabs). Electromobility shift assays were performed as
previously described (10). Off-rate experiments were
performed by adding a 500-fold molar excess of specific oligo-
nucleotides to the preformed protein–DNA complexes.
Complexes formed during the band shift reactions were sepa-
rated on pre-cooled, pre-run (1 h, 200 V) 4% polyacrylamide
gels containing 0.25× TBE at 4°C and 200 V.
Transcription templates
The annealed RORβ-specific response elements were cloned
into the SacI site of plasmid TK38[380] (14), containing the tk
minimal promoter –38 to +1 linked to a 380 bp G-less cassette.
The template 4RE1 contains four copies of the annealed RE1
element cloned into the SacI site of TK38[380]. The 5′-located
RE1 element is in the antisense orientation, the three 3′-located
elements in the sense orientation. In addition, the following
templates were used: a RARβ[380] G-less construct (11), a
TI[320] G-less construct (15) and the HIV-1 core promoter
carrying five Gal4 recognition sites (16).
In vitro transcription assays
Aliquots of 10 ml packed cell volume (PCV) of HeLa cells and
3 ml PCV of Neuro2A cells were used to prepare crude nuclear
extracts (17). The nuclear extracts had a final KCl concentra-
tion of 400 mM. A typical nuclear extract preparation had a
protein concentration of 5–8 mg/ml. Transcription reactions
were performed as described (10). The final KCl concentration
in the transcription buffer for RXRα–His6–RARα and Gal–VP16
transcription were set to 80 mM, for RORβ transcription to
50 mM. Aliquots of 4–8 µg crude nuclear extract preparations
were used per reaction. A typical transcription reaction was
performed by preincubating the samples for 40 min at 30°C in
the absence of nucleotides. After addition of nucleotides the
procedure was followed for up to 60 min reaction time. Single
round transcription experiments were performed by adding
Sarkosyl to a final concentration of 0.05% 30 s after nucleotide
addition.
RESULTS
Expression of RORβ using the vaccinia virus system
To assess the transcriptional properties of RORβ, a histidine-
tagged fusion protein, His6–RORβ, was expressed in HeLa
cells using the vaccinia virus expression system and purified
over a Ni2+–NTA column. The SDS–PAGE polypeptide
pattern of a typical His6–RORβ preparation revealed a
polypeptide of ∼50 kDa which was not present in preparations
from HeLa cells infected with wild-type vaccinia virus
(Fig. 1A and data not shown). Western blot analysis using a
polyclonal antiserum raised against RORβ identified the
50 kDa polypeptide as RORβ (Fig. 1B). Apart from RORβ,
other poly(His)-containing polypeptides present in vaccinia-
infected as well as in non-infected HeLa cells bind to Ni2+–NTA
(Fig. 1A, lanes 2–5 and data not shown). The purity of His6–RORβ
was estimated to be 5–10%.
Figure 1. Analysis of the Ni2+–NTA purified His6–RORβ preparation.
(A) Protein gel stained with Coomassie brilliant blue R-250. (B) Western blot
analysis of the Ni2+–NTA purified receptor preparation. M, molecular mass
marker. The position at which His6–RORβ migrates is indicated.
3426 Nucleic Acids Research, 2001, Vol. 29, No. 16
RORβ has a weak affinity for its DNA site
Since DNA binding of a transcription factor is a prerequisite
for transcriptional activation, the DNA-binding properties of
His6–RORβ were analysed in electrophoretic mobility shift
assays. Several oligonucleotides were used containing either a
single or two consensus half-sites (AGGTCA) in a direct or
palindromic configuration (Fig. 2A). Because DNA binding of
RORα and RORβ reportedly depends on sequences 5′ of the
consensus half-site (7,8,18), the ROR-responsive element
(RORE) used throughout the experiments contained a thymine
at position –1 and an adenine at position –4 preceeding the
nuclear receptor half-site. His6–RORβ readily bound as a
monomer to a single half-site (RE1) (Fig. 2B, left). Two
complexes were obtained on POP, a binding site containing
two half-sites in a palindromic configuration (Fig. 2B, middle).
In agreement with published results (8,19), two distinct
complexes were also detected using response elements
consisting of two half-sites arranged as direct repeats with 7 or
8 spacing nucleotides (DR+7 and DR+8; data not shown). Both
protein–DNA complexes were supershifted with a RORβ-
specific antiserum, whereas the preimmune serum did not alter
the mobility of the complexes (Fig. 2C). Binding of His6–
RORβ to TREpal, containing two palindromically arranged
consensus binding sites without appropriate 5′-extensions, was
very inefficient; a weak protein–DNA complex migrating at
the position of a monomer was obtained only at high receptor
concentrations (Fig. 2B, right).
Next, the relative affinity of His6–RORβ for the RORE was
assessed. For this purpose, off-rate experiments were
performed and compared with those of the related RXRα–
His6–RARα heterodimer (Fig. 2D). In these assays vaccinia-
expressed receptors were preincubated with labelled oligo-
nucleotide probes to allow formation of protein–DNA
complexes. Dissociation of the pre-formed protein–DNA
complexes was measured as a function of time by loading
aliquots onto a continuously running acrylamide gel at 0, 1, 4
and 16 min after addition of a 500-fold molar excess of
specific cold competitor. While the RXRα–His6–RARα
heterodimer complex bound to the RAREβ2 element was not
or only marginally affected by addition of excess competitor
(Fig. 2D, right; 20), His6–RORβ–DNA complexes formed on
the POP element dissociated rapidly after addition of competitor
(Fig. 2D, left). Similar results were obtained using other
ROREs (RE1, DR+8 and DR+7) (data not shown).
Taken together, these data show that His6–RORβ can bind to
elements that contain either one or two extended binding sites.
However, His6–RORβ has a low affinity for the response
elements tested compared with the affinity of the related
nuclear receptor heterodimer RXRα–His6–RARα for
RAREβ2.
Transcriptional activation in Neuro2A and HeLa nuclear
extracts
To assess the transcriptional activity of His6–RORβ, we estab-
lished an in vitro transcription system similar to that described
for the RXRα–His6–RARα heterodimer (10,11). The reporter
construct contained a RORE in front of the TATA box of the tk
promoter fused to a G-less cassette of 380 nt (Fig. 3A). A
template with the adenovirus major late TATA box initiator
fused to a G-less cassette of 320 nt (TI) served as an internal
control, monitoring the basal transcriptional activity of the
extracts. Since RORβ is expressed predominantly in neuronal
tissues, nuclear extracts from the neuroblastoma cell line
Neuro2A were used in initial experiments as a source of basal
transcription factors and putative cofactors. For quantitative
analysis, transcription levels were measured using a Phos-
phorimager.
His6–RORβ preparations boosted the level of transcription
up to 30-fold from the palindromic POP element-containing
template in a concentration-dependent manner, whereas the
Figure 2. DNA binding behavior of RORβ. (A) Binding sites used in this
study. The conserved nuclear receptor half-site is symbolised by an arrow, the
5′-extension of the half-site by a box. The nucleotides within the extensions
that are critical for RORβ DNA binding are marked with an asterisk. (B and C)
EMSA analysis of RORβ DNA binding to distinct binding sites, which are
indicated below the experiments. (C) Aliquots of 27 ng RORβ preparation
(lanes 2–6) and 0.1 or 1 µl of a RORβ-specific polyclonal antibody (lanes 3
and 4) or pre-bleed (lanes 5 and 6) serum were used. (D) Off-rate analysis of
RORβ binding to a POP element and RXRα–RARα binding to a RAREβ2
element.
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levels of transcription from the internal control were not or
only marginally affected (Fig. 3B, lanes 1–4; Fig. 3C, lanes 1
and 2; Fig 3D, lanes 1–4). The increase in levels of transcrip-
tion is specific for His6–RORβ because control extracts
derived from wild-type vaccinia virus-infected cells did not
boost the level of transcription from the specific reporters
(Fig. 3B, lanes 5–7). Furthermore, His6–RORβ-dependent
transcription was very low to undetectable when a reporter was
used containing the TREpal element that did not support
binding of RORβ (Fig. 2B right and Fig. 3B, lanes 8–10).
Maximal transactivation by His6–RORβ was observed with a
template containing four extended binding sites (4RE1)
(Fig. 3C and data not shown). Taken together, the ability of
His6–RORβ to bind to the ROREs correlates with its ability to
mediate transcription through these elements.
Next, we wanted to compare the transcriptional activities of
RORβ and RXRα–RARα. We previously showed that RXRα–
His6–RARα is a transcriptional activator in HeLa nuclear
extracts when a transcription template was used that contained
a fragment of the RARβ2 promoter with two natural DR5
elements (RAREβ2) (11). Therefore, in vitro transcription
reactions were performed with His6–RORβ and RXRα–His6–
RARα in Neuro2A and HeLa nuclear extracts.
RXRα–His6–RARα strongly boosted transcription from the
RARβ2 promoter-containing template in the neuronal extracts
(Fig. 3C, lanes 7 and 8). In addition, RXRα–His6–RARα acti-
vated transcription very efficiently from a template containing
a TREpal binding site in front of the minimal tk promoter,
which is identical to the POP–tk reporter except for the 4 bp
flanking the palindromic element, the so-called 5′-extension
(Fig. 3C, lanes 9 and 10). Loading the heterodimer with all-
trans retinoic acid did not further enhance the level of tran-
scription under the conditions used in these experiments (data
not shown). The experiments revealed that RORβ and RXR–
RAR are comparably efficient in transcriptional activation in
Neuro2A nuclear extracts in vitro.
When the transcriptional activities of His6–RORβ and
RXRα–His6–RARα were compared in HeLa nuclear extracts,
only few transcripts instigated by His6–RORβ could be
detected using templates containing the POP binding site
(Fig 3D, lanes 5–8). RORβ was also unable to activate tran-
scription efficiently from templates containing two extended
binding sites arranged as direct repeats (DR+7 and DR+8) or
four extended binding sites (4RE1) (data not shown). In
contrast, RXRα–His6–RARα activated transcription very
efficiently from RARβ2 (Fig. 3D, lanes 9 and 10), as well as
from the TREpal template (Fig. 3D, lanes 11 and 12), indi-
cating that the HeLa nuclear extracts were capable of
supporting activated transcription.
Taken together, RORβ is a strong transcriptional activator in
Neuro2A but not in HeLa nuclear extracts in vitro.
RORβ supports formation of functional preinitiation
complexes
The insufficiency of RORβ to activate transcription in HeLa
nuclear extracts prompted us to investigate whether RORβ is
able to support the formation of an active preinitiation complex
(PIC) in Neuro2A and HeLa nuclear extracts.
The formation of functional PICs can be measured by single
round transcription assays (21). One commonly used method
to restrict transcription to a single round in vitro is addition of
Figure 3. RORβ is a strong transcriptional activator in Neuro2A nuclear
extracts in vitro. (A) In vitro transcription templates used in this study. RORE,
RORβ-specific response element. RARβ2, fragment of the RARβ2 promoter
containing two DR5 elements. (B–D) In vitro transcription assays using
Neuro2A (B–D) or HeLa (D) nuclear extracts. The vaccinia-expressed pro-
teins used in the experiments are indicated above, the response elements of the
in vitro transcription templates below the experiments. vwt, vaccinia wild-type
nuclear extract. (C) Aliquots of 0.2 µg vaccinia-expressed His6–RORβ and
vaccinia-expressed RXRα–His6–RARα were added to the in vitro transcrip-
tion templates when indicated.
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the anionic detergent Sarkosyl shortly after transcription reac-
tions have been started by addition of nucleotides. Addition of
a defined concentration of Sarkosyl prevents PIC assembly as
well as formation of the first phosphodiester bonds, but not
elongation of an initiated transcript (22). To define the optimal
conditions in our experimental set-up (schematic presentation
in Fig. 4A), the transcriptional activity of RORβ was analysed
at different Sarkosyl concentrations. Addition of Sarkosyl to a
final concentration of up to 0.025% during PIC assembly (a) or
to a final concentration of up to 0.05% prior to formation of the
first phosphodiester bonds (b) prevented transcription (Fig. 4B,
lanes 1, 2, 7, 8, 13 and 14, and 3, 4, 9, 10, 15 and 16, respec-
tively), indicating that these processes cannot take place under
these conditions. Addition of 0.05% (final concentration)
Sarkosyl 30 s after addition of nucleotides (c), i.e. after the
formation of the first phosphodiester bonds, resulted in a low
but appreciable level of transcription, consistent with only one
round of transcription (Fig. 4B, lanes 17 and 18 and Fig. 4D).
Addition of higher concentrations of Sarkosyl (0.08%)
prevented transcription altogether (Fig. 4B, lanes 19–24).
These results suggest that adding Sarkosyl to a final concentra-
tion of 0.05% immediately following addition of nucleotides
limits transcription to a single round (single round condition).
The underlying assumption of this interpretation is that forma-
tion of PICs is saturated after 40 min.
To test this hypothesis, in vitro transcription reactions with
RORβ were preincubated under single round conditions for
different time periods (Fig. 4C). In our experimental system
10–15 min preincubation was necessary to detect the first
RORβ-dependent transcripts. The level of transcription did not
further increase after 40 min, indicating that saturation of PIC
formation was reached.
To assess the ability of RORβ to support single round tran-
scription in HeLa and Neuro2A nuclear extracts, in vitro tran-
scription experiments under single and multiple round
conditions were performed with RORβ and RXRα–His6–
RARα. Experiments with the unrelated transcription factor
Gal–VP16 served as additional controls. In vitro transcription
experiments with His6–RORβ were performed with templates
containing either the 4RE1 or the POP binding site. His6–
RORβ behaved in a similar fashion on both templates. In the
experiments presented templates with the 4RE1 binding site
were used. The transcriptional activity of RXRα–His6–RARα
was analysed on templates containing a fragment of the
RARβ2 promoter. In single round assays only transcription
from the specific template was examined to avoid competition
between the templates. To ensure reproducibility of the exper-
iments, every experiment was repeated several times; the
experiments presented are typical examples.
Figure 5 demonstrates that His6–RORβ, RXRα–His6–RARα
and Gal–VP16 were able to support low but consistent single
round transcription in Neuro2A (Fig. 5A) and HeLa (Fig. 5B)
nuclear extracts (lanes 4, 8 and 12, respectively). Thus all three
proteins, including RORβ, promoted preinitiation complex
formation in Neuro2A and HeLa nuclear extracts.
Next, we determined the ratio of transcripts under multiple
and single round conditions [indicated in Figs 4–6 as the ratio
(mr)/(sr)] for His6–RORβ, RXRα–His6–RARα and Gal–VP16
in Neuro2A and HeLa nuclear extracts. In Neuro2A nuclear
extracts, His6–RORβ, RXRα–His6–RARα and Gal–VP16 (Fig.
5A, lanes 1–4, 5–8 and 9–12, respectively) efficiently instigated
transcription under multiple round conditions. In HeLa nuclear
extracts, however, efficient transactivation under multiple
round conditions could be observed for RXRα–His6–RARα
Figure 4. RORβ can efficiently support single round transcription in vitro.
(A) Scheme of the in vitro transcription reaction. After a preincubation for
40 min, the transcription reactions were started by addition of nucleotide tri-
phosphates (NTPs), followed by a further 60 min reaction. Sarkosyl was added
at different time points either before preincubation (a), 30 s before (b) or after
(c) addition of nucleotides. (B) In vitro transcription reactions in which Sarkosyl
was added according the scheme of (A) to different final concentrations.
(C) In vitro transcription reactions under single round conditions with different
preincubation times. (D) In vitro transcription reactions under multiple round
and single round conditions. The levels of transcription obtained when Sarkosyl
was added 30 s after addition of nucleotides (single round conditions) were
normalised to 1 for each RORβ concentration. The quotient between the
amount of transcripts in a specific experiment and the amount of transcripts
under single round conditions [ratio (mr)/(sr)] is indicated below the experi-
ments.
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(Fig. 5B, lanes 5–8) and Gal–VP16 (Fig. 5B, lanes 9–12), but
not for His6–RORβ (Fig. 5B, lanes 1–4). The number of tran-
scripts instigated by RORβ in HeLa nuclear extracts under
multiple to single round conditions was approximately equal.
The observed difference in transcriptional behavior of His6–
RORβ and RXRα–His6–RARα may have been caused by the
differential requirements of the basal promoter used in these
experiments, i.e. the minimal tk versus the RARβ2 promoter.
To rule this out, the experiments were repeated for RXRα–
His6–RARα using an artificial template that contained a
TREpal binding site in front of the minimal tk promoter.
RXRα–His6–RARα activated transcription efficiently from
this template in Neuro2A as well as in HeLa nuclear extracts,
indicating that the basal promoter composition of the templates
did not influence the transcriptional behavior of the proteins
(Fig. 5C). Taken together, these experiments suggest a
different transcriptional behavior of the two nuclear receptors
RORβ and RXRα–RARα in HeLa nuclear extracts in vitro.
The observation that His6–RORβ instigated significantly
more transcripts in Neuro2A as compared with HeLa nuclear
extracts prompted us to assess the rate at which His6–RORβ
boosts formation of functional preinitiation complexes in
Neuro2A and HeLa nuclear extracts. As already demonstrated
in Figure 4C, the rate of PIC assembly can be measured by
performing experiments under single round conditions at
different preincubation times. In Neuro2A as well as HeLa
nuclear extracts, transcripts were synthesised in the presence of
RORβ proportional to the time of preincubation (Fig. 6A).
These experiments suggest that His6–RORβ recruits PICs with
equal efficiency in Neuro2A and HeLa nuclear extracts. Thus,
the low amount of transcripts instigated by RORβ in HeLa
nuclear extracts is not due to an extract-dependent insuffi-
ciency in the formation of functional PICs.
Figure 5. In vitro transcription reactions with RORβ, RXRα–RARα and Gal–
VP16 under single and multiple round conditions using Neuro2A (A) and
HeLa (B) nuclear extracts. (C) In vitro transcription reaction in Neuro2A and
HeLa nuclear extracts with RXRα–RARα using an artificial template with a
TREpal binding site. Aliquots of 0.2 µg RORβ or RXRα–RARα and 80 ng
Gal–VP16 were added when noted. The levels of transcription obtained when
Sarkosyl was added 30 s after addition of nucleotides (single round conditions)
were normalised to 1 for each experimental set-up. The quotient between the
amount of transcripts in a specific experiment and the amount of transcripts
under single round conditions [ratio (mr)/(sr)] is indicated below the experi-
ments.
Figure 6. RORβ-dependent transcription is insufficient in HeLa nuclear
extracts. (A) In vitro transcription assays under single round conditions in
Neuro2A and HeLa nuclear extracts with different preincubation times.
(B) In vitro transcription reactions were preincubated for 40 min, started with
nucleotides and then incubated under multiple round conditions for the
indicated times. Transcription reactions in lanes 1, 2, 9 and 10 were performed
under single round conditions with a reaction time of 60 min. (C) The same
experimental set-up as in (B), but with longer reaction times. The ratios (mr)/(sr)
are plotted against time. In all experiments 0.2 µg RORβ or RXRα–RARα
were added when noted.
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Next, we investigated the time required by His6–RORβ,
RXRα–His6–RARα and Gal–VP16 to synthesise the equivalent
of a single round of transcription to assess the rate at which
transcripts are synthesised in HeLa and Neuro2A nuclear
extracts. In vitro transcription experiments were performed
under multiple round conditions and stopped at different times
after addition of nucleotides (reaction times). RORβ-induced
transcripts reached the equivalent of a single round transcrip-
tion within 5 min after addition of nucleotides in Neuro2A
(Fig. 6B, left) as well as in HeLa (Fig. 6B, right) nuclear
extracts. This suggests that the rate of the synthesis of tran-
scripts instigated by RORβ does not differ significantly in
Neuro2A and HeLa nuclear extracts. Similar results were
obtained for RXRα–His6–RARα and Gal–VP16 (data not
shown).
Similar experiments were performed with longer reaction
times to assess the transcriptional efficiency of the proteins in
the extracts. In Neuro2A nuclear extracts His6–RORβ-insti-
gated transcription resulted in doubling of the amount of tran-
scripts every ∼10–13 min, whereas no further increase in the
number of transcripts could be observed in HeLa nuclear
extracts (Fig. 6C). In contrast, RXRα–His6–RARα and Gal–
VP16 continuously produced transcripts in Neuro2A as well as
in HeLa nuclear extracts.
Taken together, these experiments demonstrate that His6–
RORβ is equally efficient in supporting single round transcrip-
tion in Neuro2A and HeLa nuclear extracts. However, in vitro
the ability of RORβ to instigate transcripts is impaired in HeLa
nuclear extracts.
DISCUSSION
RORβ is an orphan member of the nuclear receptor super-
family that belongs to subfamily 1, with T3R and RAR as the
most prominent members (1). Notwithstanding the extensive
amino acid similarity between these receptors, our study
suggests that the mechanism of transcriptional activation medi-
ated by RORβ may differ from those of RAR and T3R. Firstly,
RORβ binds DNA as a monomer (8,10,19; this study), whereas
T3R and RAR require heterodimerisation with RXR (20,23). In
agreement with these results, RAR is transcriptionaly active in
vivo and in vitro only as an RXR heterodimer, while RORβ
activates transcription as a monomer (10).
In off-rate experiments the heterodimers RXRα–RARα and
RXRα–T3Rα have high affinity for their cognate DNA-
binding sites (20), whereas the affinity of RORβ (this study)
and RORα (24) for a single, as well as a double, extended half-
site is comparatively weak. Although the artificial binding
sites used in this study have been shown to be optimal for
RORβ DNA binding in vitro and for transcriptional activation
in vivo (8,19), the existence of natural ROREs with high(er)
affinities cannot be ruled out. Despite the different affinities
for their cognate binding sites, RORβ and RXRα–RARα are
equally efficient in the recruitment of functional PICs to DNA.
It is important to note that PIC formation is a rather slow
process. Several studies have determined the half-time of
complex recruitment (i.e. the preincubation time required to
obtain 50% of the final amount of transcripts generated under
single round conditions) to be between 8 and 20 min (25–27).
Saturation of PIC formation has been shown to require, as in
our study, up to ∼40 min (27).
Comparing the number of transcripts instigated by RORβ and
RXRα–RARα under single versus multiple round transcrip-
tion conditions (Fig. 5), we observed an insufficiency of HeLa
nuclear extracts to support RORβ-dependent in vitro transcrip-
tion. Whereas in Neuro2A nuclear extracts transactivation by
RORβ resulted in continuous production of transcripts, in
HeLa nuclear extracts the accumulation of transcripts ceased
after 5 min. In contrast, RXRα–RARα and the unrelated tran-
scription factor Gal–VP16 supported transcription in Neuro2A
and HeLa nuclear extracts beyond the initial 5 min of incuba-
tion. This observation shows that HeLa nuclear extracts were
in principle able to support efficient transactivation.
There are several explanations as to why transcription medi-
ated by RORβ ceased after an initial short period of transcrip-
tion in HeLa nuclear extracts. RORβ, in comparison with
RXRα–RARα and Gal–VP16, might depend more strongly on
a general factor(s) that is required for subsequent rounds of
transcription and is limited in HeLa nuclear extracts. Putative
candidates could be factors required for promoter clearance,
such as the general transcription factor TFIIH (28,29), or for
elongation of subsequent transcription rounds, such as the
elongation factor SII (30).
Another intriguing possibility is that RORβ facilitates
cofactor-dependent reinitiation in Neuro2A but not in HeLa
nuclear extracts. Several in vitro studies have shown that rein-
itiation of transcription is fast as compared to the slow first
round of transcription. In the first round of transcription, a
preinitiation complex has to be recruited to the promoter,
which appears to be a very slow process in vitro. At some
promoters a committed complex consisting of TFIID and other
factors such as TFIIA, TFIIB, TFIIH, TFIIE and Mediator has
been detected after the initial polymerase escape (29,31–34).
Such a committed complex might act as a scaffold for rapid
formation of subsequent reinitiation complexes. Whether the
continued presence of an activator is required to stabilise such
a complex is unclear (27,31,35) and may depend on the tran-
scription factor and template (29). Several activators, such as
the heat shock factor or estrogen receptor, have been shown to
enhance not only PIC assembly but also the rate of reinitiation
in cell-free systems (31,36). RORβ might instigate transcrip-
tion efficiently in Neuro2A but not in HeLa nuclear extracts
due to the presence of an extract-specific factor(s) in Neuro2A
nuclear extracts that facilitates RORβ-dependent reinitiation of
transcription. Such a factor might be a cell type-specific homo-
logue of TBP, such as TRF (37), or a cell type-specific cofactor
involved in reinitiation. Alternatively, the impaired ability of
RORβ to reinitiate transcription in HeLa nuclear extracts could
be caused by the presence of an inhibitory factor in HeLa
nuclear extracts that specifically blocks RORβ-dependent rein-
itiation.
The analysis of reinitiation mechanisms is difficult since it
requires proof that initiation of the second and later rounds
derive from the promoter already used in the first round of
transcription, i.e. it has to be excluded that the transcripts
synthesised at a later stage of incubation originate from previ-
ously untranscribed promoters. This is of particular importance
since several studies have demonstrated that in cell-free tran-
scription assays only a few per cent of the promoters are tran-
scribed (21). The experiments shown in this study do not
address the reinitiation mechanism and further experiments are
necessary to analyse whether the transcripts produced in the
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first and subsequent rounds of transcription are derived from
the same promoters.
The presence of a cell type-specific transcription mechanism
seems likely in the light of other studies. Transient transfection
studies have shown that the ligand-binding domains of RORα
(24) and RORβ (19) display a neuronal-specific transcriptional
activity when they are fused to a Gal4 DNA-binding domain.
In addition, a neuronal-specific cofactor for RORβ has recently
been identified (38). This cofactor, called NIX1, does not acti-
vate but inhibits RORβ-dependent transactivation when over-
expressed in transient transfection assays.
In summary, we have demonstrated that the orphan nuclear
receptor RORβ is a comparatively strong transcriptional acti-
vator in vitro when considering its low affinity for ROREs.
RORβ is as equally efficient as such strong DNA-binding
factors as RXRα–RARα and Gal–VP16 in PIC stabilisation
and continuous transcriptional activation in Neuro2A nuclear
extracts. We further showed that RORβ, in contrast to RXRα–
RARα and Gal–VP16, cannot instigate continuous transcrip-
tion in HeLa nuclear extracts. This observation suggests a
different (co)factor requirement for transactivation by
members of the NR1 subfamily of nuclear receptors. Fraction-
ation and further characterisation of nuclear extracts needs to
be pursued to gain insight into the mechanism of transactiva-
tion by the orphan receptor RORβ.
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